Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Recombination00:57

Viral Recombination

24.0K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.0K
Cross-reactivity00:42

Cross-reactivity

31.7K
Overview
31.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathology of green sea turtle (Chelonia mydas): Mortalities in Gladstone Harbour, Queensland, Australia, 2017-2020.

Journal of comparative pathology·2026
Same author

Tetravalent microprojection-based dengue chimeric virus vaccine raises potent neutralising antibodies in mice.

NPJ vaccines·2025
Same author

Author Correction: A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity.

Nature communications·2025
Same author

A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity.

Nature communications·2025
Same author

Tissue tropism, pathology, and pathogenesis of West Nile virus infection in saltwater crocodile (Crocodylus porosus).

PLoS neglected tropical diseases·2025
Same author

Universal Bacterium-Vectored COVID-19 Vaccine Expressing Early SARS-CoV-2 Conserved Proteins Cross-Protects Against Late Variants in Hamsters.

Vaccines·2025

Related Experiment Video

Updated: Oct 12, 2025

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.8K

Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses.

Jessica J Harrison1, Jody Hobson-Peters1, Helle Bielefeldt-Ohmann1,2

  • 1Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, Brisbane, QLD 4072, Australia.

Vaccines
|November 27, 2021
PubMed
Summary

Novel chimeric vaccines from insect-specific flaviviruses offer a safe, economical, and broadly applicable solution for combating vector-borne flavivirus diseases, addressing current vaccine limitations.

Keywords:
Binjari virusJapanese encephalitisWest Nile virus diseaseZikachimeric virusdengueflavivirusinsect-specific flavivirusvaccine platformyellow fever

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.2K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K

Related Experiment Videos

Last Updated: Oct 12, 2025

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.2K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.5K

Area of Science:

  • Virology
  • Vaccinology
  • Public Health

Background:

  • Vector-borne flaviviruses cause widespread severe disease and mortality annually.
  • Existing flavivirus vaccines face challenges in efficacy, safety, and supply, particularly in resource-limited settings.
  • There is an urgent need for new vaccine technologies that are safe, economical, and broadly applicable.

Purpose of the Study:

  • To review novel chimeric vaccine strategies for flavivirus diseases.
  • To evaluate the potential of insect-specific flavivirus-derived vaccines.
  • To identify solutions for broad flavivirus disease coverage and rapid response.

Main Methods:

  • Review of studies on chimeric flavivirus vaccines.
  • Analysis of vaccine platforms derived from insect-specific flaviviruses.
  • Assessment of safety, efficacy, and manufacturing potential.

Main Results:

  • Chimeric vaccines derived from insect-specific flaviviruses show promise.
  • These novel vaccines offer a potentially safe and simple production system.
  • The platform demonstrates potential for broad applicability across flavivirus diseases.

Conclusions:

  • Chimeric vaccines represent a promising new approach for flavivirus disease control.
  • This platform could enable economical vaccine production in resource-poor regions.
  • Further development could lead to vaccines for unmet needs and emerging threats.